Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | MAP2K1 | Q02750 | 2/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | CCR2 | P41597 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | ACACB | O00763 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | PPM1B | O75688 | 1/20 | 0.35 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.35 |
| ▸ | PPP1CC | P36873 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21662208 | 1.00 | L3MBTL1 (0.41) | L3MBTL1ALDH1A1MAP2K1HSD17B10CCR2 | |
| SCHEMBL2789189 | 0.89 | L3MBTL1 (0.54) | L3MBTL1ALDH1A1HSD17B10CCR2ATM | |
| SCHEMBL14169786 | 0.87 | L3MBTL1 (0.49) | L3MBTL1ALDH1A1HSD17B10CCR2ATM | |
| SCHEMBL11487920 | 0.81 | CYP1A2 (0.34) | CYP1A2HIF1A | |
| SCHEMBL9038834 | 0.79 | MAPK1 (0.38) | L3MBTL1ALDH1A1HSD17B10CCR2ACACB | |
| SCHEMBL907623 | 0.79 | MAPT (0.45) | ALDH1A1HSD17B10ACACBPOLBPPM1B | |
| SCHEMBL7542627 | 0.79 | MAPK1 (0.38) | L3MBTL1ALDH1A1HSD17B10CCR2ACACB | |
| SCHEMBL27405623 | 0.79 | MAPT (0.45) | ALDH1A1HSD17B10ACACBPOLBPPM1B | |
| SCHEMBL11674331 | 0.77 | — | — | |
| SCHEMBL2018377 | 0.76 | L3MBTL1 (0.46) | L3MBTL1ALDH1A1HSD17B10CCR2ACACB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 89 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250129094-A1 | NEW QUINOLINE DERIVATIVES | ELANCO ANIMAL HEALTH GMBH (DE) | 2025-04-24 | — | — | US | claimed |
| US-12071516-B2 | Polymeric stabilizing formulations | NANO PRECISION MEDICAL, INC. (US) | 2024-08-27 | — | — | US | claimed |
| EP-4399209-A1 | NEW QUINOLINE DERIVATIVES | Elanco Animal Health GmbH (DE) | 2024-07-17 | — | — | EP | claimed |
| CN-117957223-A | Quinoline derivatives | 礼蓝动物保健有限公司 | 2024-04-30 | — | — | CN | claimed |
| WO-2023036821-A1 | NEW QUINOLINE DERIVATIVES | BAYER ANIMAL HEALTH GMBH (DE) | 2023-03-16 | — | — | WO | claimed |
| EP-4148052-A1 | NEW QUINOLINE DERIVATIVES | Bayer Animal Health GmbH (DE) | 2023-03-15 | — | — | EP | claimed |
| US-20210246271-A1 | POLYMERIC STABILIZING FORMULATIONS | NANO PRECISION MEDICAL, INC. (US) | 2021-08-12 | — | — | US | claimed |
| US-11021576-B2 | Polymeric stabilizing formulations | NANO PRECISION MEDICAL, INC. (US) | 2021-06-01 | — | — | US | claimed |
| US-20200040140-A1 | POLYMERIC STABILIZING FORMULATIONS | NANO PRECISION MEDICAL, INC. (US) | 2020-02-06 | — | — | US | claimed |
| US-10479868-B2 | Polymeric stabilizing formulations | NANO PRECISION MEDICAL, INC. (US) | 2019-11-19 | — | — | US | claimed |
| US-20170274089-A1 | POLYMERIC STABILIZING FORMULATIONS | NANO PRECISION MEDICAL, INC. | 2017-09-28 | — | — | US | claimed |
| EP-2604289-B1 | RADIAL SHAPE OF POLYMER COMPOUND CONTAINING IODINE, PREPARATION METHOD THEREOF, AND CT CONTRAST MEDIUM COMPOSITION CONTAINING SAME | KOREA RES INST BIOSCIENCE & BIOTECHNOLOGY (KR) | 2017-08-16 | — | — | EP | claimed |
| US-9387267-B2 | Iodine-containing radial-shaped macromolecular compounds, preparation method thereof and contrast media compositions for CT comprising the same | KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) | 2016-07-12 | — | — | US | claimed |
| WO-2016037128-A1 | POLYMERIC STABILIZING FORMULATIONS | NANO PRECISION MEDICAL, INC. (US) | 2016-03-10 | — | — | WO | claimed |
| CN-105085930-A | Novel dendritic macromolecule and its preparation method and use | HAN BING | 2015-11-25 | — | — | CN | claimed |
| CN-104558625-A | Novel dendrimer as well as preparation and application thereof | HAN BING | 2015-04-29 | — | — | CN | claimed |
| CN-104558627-A | Novel dendrimer as well as preparation and application thereof | HAN BING | 2015-04-29 | — | — | CN | claimed |
| CN-103282056-A | Iodine-containing radial macromolecular compound, preparation method thereof and CT contrast medium composition containing same | KOREA RES INST OF BIOSCIENCE | 2013-09-04 | — | — | CN | claimed |
| EP-2604289-A2 | RADIAL SHAPE OF POLYMER COMPOUND CONTAINING IODINE, PREPARATION METHOD THEREOF, AND CT CONTRAST MEDIUM COMPOSITION CONTAINING SAME | Korea Research Institute of Bioscience and Biotechnology (KR) | 2013-06-19 | — | — | EP | claimed |
| US-20130150529-A1 | IODINE-CONTAINING RADIAL-SHAPED MACROMOLECULAR COMPOUNDS, PREPARATION METHOD THEREOF AND CONTRAST MEDIA COMPOSITIONS FOR CT COMPRISING THE SOME | KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) | 2013-06-13 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170274089-A1 | POLYMERIC STABILIZING FORMULATIONS | IAPP, INSR, GPR119 | L3MBTL1 4640/4885ALDH1A1 2610/4885MAP2K1 4588/4885 |
| US-11021576-B2 | Polymeric stabilizing formulations | IAPP, INSR, GPR119 | L3MBTL1 4640/4885ALDH1A1 2610/4885MAP2K1 4588/4885 |
| US-20130150529-A1 | IODINE-CONTAINING RADIAL-SHAPED MACROMOLECULAR COMPOUNDS, PREPARATION METHOD THEREOF AND CONTRAST MEDIA COMPOSITIONS FOR CT COMPRISING THE SOME | IGFBP1, IGFBP5, IGFBP2 | L3MBTL1 4845/4885ALDH1A1 4766/4885MAP2K1 913/4885 |
| US-12071516-B2 | Polymeric stabilizing formulations | VEGFA, CD44, CFTR | L3MBTL1 2388/4885ALDH1A1 3181/4885MAP2K1 4769/4885 |
| US-10479868-B2 | Polymeric stabilizing formulations | IAPP, INSR, GPR119 | L3MBTL1 4640/4885ALDH1A1 2610/4885MAP2K1 4588/4885 |
| US-20250129094-A1 | NEW QUINOLINE DERIVATIVES | RECQL, QTRT2, NQO2 | L3MBTL1 2122/4885ALDH1A1 1516/4885MAP2K1 4433/4885 |
| US-20200040140-A1 | POLYMERIC STABILIZING FORMULATIONS | IAPP, INSR, GPR119 | L3MBTL1 4640/4885ALDH1A1 2610/4885MAP2K1 4588/4885 |
| US-20210246271-A1 | POLYMERIC STABILIZING FORMULATIONS | VEGFA, CD44, CFTR | L3MBTL1 2388/4885ALDH1A1 3181/4885MAP2K1 4769/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.